Novatel Wireless Telematics Solutions Lead to Recovery of Stolen Fuel Tankers
Jan 11, 2016 13:34 pm UTC| Business
SAN DIEGO, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Ctrack telematics solutions from Novatel Wireless, Inc. (NASDAQ:MIFI) recently aided authorities in the recovery of two fuel tankers valued over $1,000,000 that were stolen in...
CGG: SHAREHOLDERS' MEETING OF CGG OF 11 JANUARY 2016
Jan 11, 2016 13:33 pm UTC| Business
PARIS, Jan. 11, 2016 (GLOBE NEWSWIRE) -- The shareholders' meeting of CGG was held today under the chairmanship of Mr Rmi Dorval, Chairman of the Board of directors. Shareholders adopted all of the resolutions supported...
Jan 11, 2016 13:32 pm UTC| Business
SAN JOSE, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Sphere 3D Corp. (NASDAQ:ANY), a containerization, virtualization and data management solutions provider and parent company of Overland Storage and Tandberg Data, today...
Carpenter Technology Announces Conference Call and Webcast
Jan 11, 2016 13:30 pm UTC| Business
WYOMISSING, Pa., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE:CRS) plans to host a conference call and webcast on Thursday, February 4, 2016 at 10:00 a.m. ET to discuss the results of...
McDermott Appoints Murray as Vice President, Treasurer and Investor Relations
Jan 11, 2016 13:30 pm UTC| Business
HOUSTON, Jan. 11, 2016 (GLOBE NEWSWIRE) -- McDermott International, Inc. (NYSE:MDR) announced today that Kathy Murray has been appointed Vice President, Treasurer and Investor Relations. Ms. Murray adds the role of...
PositiveID Corporation Announces 2015 Highlights and 2016 Outlook
Jan 11, 2016 13:30 pm UTC| Business
DELRAY BEACH, Fla., Jan. 11, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today a summary of 2015...
OncoMed Enrolls First Patient in Phase 1b Anti-RSPO3 Trial
Jan 11, 2016 13:30 pm UTC| Business
REDWOOD CITY, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical-stage company developing novel anti-cancer stem cell and immuno-oncology therapeutics, today announced that...